ONO-2952

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameONO-2952
Drug Alias NameONO-2952
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranslocator protein inhibitors
TargetsTranslocator protein
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOno Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOno Pharmaceutical Co LtdOno Pharma Usa Inc
Active IndicationsN/A
Inactive IndicationsIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A